『Back on Track: Achieving Healthy Weight Loss』のカバーアート

Back on Track: Achieving Healthy Weight Loss

Back on Track: Achieving Healthy Weight Loss

著者: Alicia Shelly
無料で聴く

Back on Track: Achieving Healthy Weight Loss is a podcast that focuses on helping people get back on track and stay on track with their weight loss journey. This podcast focuses on improving your Mindset, Motivation and Momentum in your weight loss journey.Copyright 2021 Healthy Living LLC, All rights reserved 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Episode 248: Am I Going to Go Blind on a GLP-1? Understanding the NAION Headlines
    2026/07/13

    If you've seen headlines linking Ozempic and other GLP-1 medications to sudden eye strokes, I want to stop the panic right here.

    In this episode, I break down what the research on NAION actually shows, who's really at risk, and why the scary relative-risk numbers you're seeing online don't tell the whole story.

    I walk you through what NAION is, why patients on semaglutide often already carry the underlying risk factors that get left out of the clickbait, and what the difference is between an observational study raising a signal and a randomized trial proving cause and effect. I also share the warning signs that mean you should go to the ER immediately, not wait for your next appointment.

    You'll walk away knowing exactly how to think about this headline, what questions to bring to your own doctor, and why staying on your medication is usually the right call.

    Episode Highlights:

    • What NAION is and how it affects the optic nerve

    • The risk factors patients on GLP-1s often already have

    • What the 37-million-person study actually found — and didn't

    • Why randomized trials tell a different story than observational data

    • Absolute risk vs. relative risk, explained simply

    • Warning signs that mean go to the ER now

    • Why sleep apnea complicates the whole picture

    Connect with Dr. Alicia Shelly:

    • Website | drshellymd.com

    • Facebook | www.facebook.com/drshellymd

    • Instagram | @drshellymd

    • Linked In | www.linkedin.com/in/drshellymd

    • Twitter | @drshellymd

    About Dr. Alicia Shelly

    Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.

    Resources:

    FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!) 👉 Click

    続きを読む 一部表示
    11 分
  • Episode 249: Do I Have to Stay on My Medication Forever? What the ATTAIN Maintain Trial Reveals
    2026/07/20

    "Doc, do I need to take this forever?" It's one of the most common questions I hear in my office, whether it's someone's very first visit or someone who's already lost 30, 40, even 80 pounds and is feeling great.

    In this episode, I break down why your body fights so hard to regain weight after you lose it, and why that's biology, not failure. I walk through the new ATTAIN Maintain trial, a study of 376 adults who had already lost significant weight on tirzepatide or semaglutide, testing whether switching to an easier once-daily oral GLP-1 could help them keep the weight off, instead of just asking whether stopping medication causes regain.

    Maintenance isn't about staying on one medication forever. It's about having an individualized, active plan, and the ATTAIN Maintain data gives us more options than ever to build one.

    Episode Highlights:

    • Why your metabolism and hunger hormones fight to reverse weight loss

    • Lessons from the SURMOUNT-4 trial on what happens when treatment stops completely

    • Inside the ATTAIN Maintain trial design and who was studied

    • The weight maintenance results: oral medication vs. placebo

    • Why maintenance therapy doesn't have to look like the treatment that got you there

    • What actually goes into a sustainable long-term plan beyond medication

    Connect with Dr. Alicia Shelly:

    • Website | drshellymd.com

    • Facebook | www.facebook.com/drshellymd

    • Instagram | @drshellymd

    • Linked In | www.linkedin.com/in/drshellymd

    • Twitter | @drshellymd

    About Dr. Alicia Shelly

    Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.

    Resources:

    FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!) 👉 Click

    続きを読む 一部表示
    13 分
  • Episode 247: The Menopause Metabolism Shift: How Foundayo Changes the Game
    2026/06/29

    I hear this from so many of my patients: "Dr. Shelly, I haven't changed anything—not my diet, not my exercise—but I'm gaining weight and my body just doesn't respond the way it used to." If you're a woman in your 40s or 50s, you're probably nodding right now.

    In this episode, I'm walking you through exactly why menopause causes weight gain, why it has nothing to do with willpower, and what breakthrough new research reveals about Foundayo—an oral GLP-1 medication—and how it helps restore the biological signals that become harder to access during this life stage.

    I'm sharing real data from the 2026 American Diabetes Association Scientific Conference, including results from the ATTAIN 1 and ATTAIN 2 clinical trials that show meaningful weight loss across all menopausal stages.

    But here's what matters most: the goal during menopause isn't just weight loss—it's aging healthy.

    You'll learn exactly what that looks like and what you need to focus on right now.

    Episode Highlights:

    • What menopause actually is (

    • How estrogen decline drives abdominal fat storage and insulin resistance

    • Why muscle loss and poor sleep compound weight gain

    • How GLP-1 medications work—and what they don't do

    • The ATTAIN trials: weight loss results before, during, and after menopause

    • Strength training, protein intake, and the non-negotiables for sustainable results

    REFERENCES:

    • Menopausal Stage and Weight Outcomes with Orforglipron vs. Placebo: Post Hoc Subgroup Analysis from ATTAIN-1 and ATTAIN-2. Presented at the 86th Scientific Sessions of the American Diabetes Association, June 2026.

    • Horn DB, et al. Orforglipron, an oral small-molecule GLP-1 receptor agonist, for obesity treatment in adults with type 2 diabetes. Lancet. 2026.

    • ClinicalTrials.gov. ATTAIN-2 Trial (NCT05872620).

    • The Menopause Society. Menopause practice recommendations and patient resources on metabolic changes during menopause.

    Connect with Dr. Alicia Shelly:

    • Website | drshellymd.com

    • Facebook | www.facebook.com/drshellymd

    • Instagram | @drshellymd

    • Linked In | www.linkedin.com/in/drshellymd

    • Twitter | @drshellymd

    About Dr. Alicia Shelly

    Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.

    Resources:

    FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!) 👉 Click

    続きを読む 一部表示
    19 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません